title: Topical psoralen plus UV-A therapy for tyrosine kinase inhibitor-induced hand-foot syndrome.
authors.forename: Willemijn E M
authors.initials: WE
authors.lastname: Bos
authors.forename: Tamar E C
authors.initials: TE
authors.lastname: Nijsten
authors.forename: Maja J A
authors.initials: MJ
authors.lastname: de Jonge
authors.forename: A P
authors.initials: AP
authors.lastname: Hamberg
mesh_terms: D001549:Benzamides; D005260:Female; D060831:Hand-Foot Syndrome / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D007211:Indoles / Q000009:adverse effects; D008297:Male; D011701:PUVA Therapy; D010879:Piperazines / Q000009:adverse effects; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects; D011758:Pyrroles / Q000009:adverse effects; D000077210:Sunitinib
chemical_list: D001549:Benzamides; D007211:Indoles; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011758:Pyrroles; D000068877:Imatinib Mesylate; D000077210:Sunitinib